Effects of N-ethoxycarbonyl-3-morpholinosyndnonimine (SIN-10) on the cardiovascular system.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007097:Imines / Q000494:pharmacology; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010069:Oxadiazoles / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D000959:Antihypertensive Agents; D006584:Hexamethonium Compounds; D007097:Imines; D009025:Morpholines; D010069:Oxadiazoles; D005996:Nitroglycerin; D009638:Norepinephrine